Literature DB >> 3819698

Role of prostaglandins and non-steroid anti-inflammatory drugs in the pathogenicity of vaccinia virus.

G Zavagno, B Jaffe, M Esteban.   

Abstract

The effect of prostaglandins (PGs) of the A series (A1 and dimethyl PGA2), E1, D2, F2 alpha and PGI2 (prostacyclin) and of inhibitors of PG synthesis (aspirin and indomethacin) on the pathogenicity of vaccinia virus was studied in BALB/c mice. PGs of the A series, D2 and F2 alpha conferred little or no protection to mice against the lethal effects of vaccinia virus. Mice treated with PGE1 showed a dramatic increase in mortality after viral infection. However, when mice were treated with PGI2, their survival was greatly enhanced. Mice treated with aspirin and indomethacin showed a marked increase in mortality. Increased mortality correlated with higher virus yields in target tissues (spleen) and with inhibition of antibody response, whereas the increase in survival correlated with lower virus yields and with normal antibody responses. The significance of our findings is that PGI2 can block the outcome of the disease caused by vaccinia virus whereas other PGs and their inhibitors not only worsen the disease, but may activate and enhance viral infections through immune suppression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819698     DOI: 10.1099/0022-1317-68-2-593

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Authors:  E Paez; S Dallo; M Esteban
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

2.  A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.

Authors:  Cary A Rue; Michael A Jarvis; Amber J Knoche; Heather L Meyers; Victor R DeFilippis; Scott G Hansen; Markus Wagner; Klaus Früh; David G Anders; Scott W Wong; Peter A Barry; Jay A Nelson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta.

Authors:  Myungsoo Joo; Young S Hahn; Minjae Kwon; Ruxana T Sadikot; Timothy S Blackwell; John W Christman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 4.  Protease-activated receptors and prostaglandins in inflammatory lung disease.

Authors:  Terence Peters; Peter J Henry
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

5.  Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.

Authors:  Koichi Hashimoto; Barney S Graham; Mark W Geraci; Garret A FitzGerald; Karine Egan; Weisong Zhou; Kasia Goleniewska; Jamye F O'Neal; Jason D Morrow; Russell K Durbin; Peter F Wright; Robert D Collins; Tatsuo Suzutani; R Stokes Peebles
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Therapeutic and prophylactic drugs to treat orthopoxvirus infections.

Authors:  Scott Parker; Lauren Handley; R Mark Buller
Journal:  Future Virol       Date:  2008-11       Impact factor: 1.831

7.  Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.

Authors:  J B Moore; G L Smith
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.